Greif GEF Effect of exchange rate changes on cash, cash equivalents and restricted cash

Effect of exchange rate changes on cash, cash equivalents and restricted cash at other companies

ConstelliumCSTM

-$2M-150%

Sonoco ProductsSON

——

West Pharmaceutical ServicesWST

——

Other financials

Income statement

See full

Revenue$1.1B-0.5%

Gross profit$247.0M-0.6%

Operating income$35.4M-41.7%

Net income$12.6M-68.4%

EPS (diluted)$1.16-24.6%

Balance sheet

See full

Cash & equivalents$286.1M+42.3%

Total debt$1.2B-60.8%

Total equity$2.9B+44.2%

Total assets$5.6B-15.0%

Cash flow

See full

Operating cash flow$116.6M+479%

CapEx$56.8M+59.1%

Free cash flow$59.8M+190%

Valuation

See full

Market cap$3.97B+19.8%

Profitability

See full

Gross margin22.4%+1.6pp

Operating margin10.5%+3.4pp

Net margin6.5%+2.3pp

FCF margin5.8%—

Returns & leverage

See full

Return on equity12%+2.4pp

Debt / equity0.4×-1.1×

Current ratio1.3×0.0×

Where this comes from

Reported directly by Greif in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Greif’s 10-Q, filed January 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Greif's effect of exchange rate changes on cash, cash equivalents and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Greif's effect of exchange rate changes on cash, cash equivalents and restricted cash?: Greif (GEF) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of $13.6M in Q4 2025.
How has Greif's effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?: Greif's effect of exchange rate changes on cash, cash equivalents and restricted cash increased by 142.4% year-over-year, from -$32.1M to $13.6M.